
( (S 
    (NP-SBJ 
      (NP (JJ Federal) (NN drug) (NNS regulators) )
      (, ,) 
      (ADJP (VBN concerned) 
        (PP (IN over) 
          (NP (JJ British) (NNS reports) 
            (SBAR (IN that) 
              (S 
                (NP-SBJ-1 (NNS diabetics) )
                (VP (VBP have) 
                  (VP (VBN died) 
                    (PP-TMP (IN after) 
                      (S-NOM 
                        (NP-SBJ (-NONE- *-1) )
                        (VP (VBG shifting) 
                          (PP-CLR (IN from) 
                            (ADJP (JJ animal) ))
                          (PP-CLR (TO to) 
                            (NP (JJ human-based) (NN insulin) ))))))))))))
      (, ,) )
    (VP (VBP say) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ (PRP they) )
          (VP (VBP are) 
            (VP (VBG considering) 
              (NP 
                (NP (DT a) (NN study) )
                (SBAR 
                  (WHNP-2 (-NONE- 0) )
                  (S 
                    (NP-SBJ (-NONE- *T*-2) )
                    (VP (TO to) 
                      (VP (VB see) 
                        (SBAR (IN if) 
                          (S 
                            (NP-SBJ (JJ similar) (NNS deaths) )
                            (VP (VB have) 
                              (VP (VBN occurred) 
                                (ADVP-LOC (RB here) )))))))))))))))
    (. .) ))
( (S 
    (NP-SBJ (DT The) (NNP United) (NNP Kingdom) (NNS reports) )
    (VP (VBD came) 
      (PP-DIR (IN from) 
        (NP 
          (NP (NNP Dr.) (NNP Patrick) (NNP Toseland) )
          (, ,) 
          (NP 
            (NP (NN head) )
            (PP (IN of) 
              (NP (JJ clinical) (NN chemistry) ))
            (PP-LOC (IN at) 
              (NP 
                (NP 
                  (NP (NNP Guy) (POS 's) )
                  (NNP Hospital) )
                (PP-LOC (IN in) 
                  (NP (NNP London) ))))))))
    (. .) ))
( (S 
    (PP-LOC (IN In) 
      (NP (DT a) (NN telephone) (NN interview) ))
    (NP-TMP (NNP Friday) )
    (, ,) 
    (NP-SBJ (NNP Dr.) (NNP Toseland) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ 
            (NP (DT the) (NN number) )
            (PP (IN of) 
              (NP 
                (NP (JJ sudden) 
                  (, ,)
                  (JJ unexplained) (NNS deaths) )
                (PP (IN of) 
                  (NP (NNS diabetics) ))))
            (SBAR 
              (WHNP-1 (-NONE- 0) )
              (S 
                (NP-SBJ (PRP he) )
                (VP (VBD had) 
                  (VP (VBN seen) 
                    (NP (-NONE- *T*-1) )
                    (NP-TMP (DT this) (NN year) ))))))
          (VP (VBD was) 
            (NP-PRD 
              (NP (CD 17) )
              (PP (VBN compared) 
                (PP (IN with) 
                  (NP 
                    (NP (RB just) (CD two) )
                    (PP-TMP (IN in) 
                      (NP (CD 1985) ))))))))))
    (. .) ))
( (S 
    (S-TPC-2 
      (NP-SBJ 
        (NP 
          (QP (IN At) (JJS least) (CD six) ))
        (PP (IN of) 
          (NP (DT the) (NNS deaths) )))
      (VP (VBD occurred) 
        (PP-LOC (IN among) 
          (NP 
            (NP 
              (ADJP (RB relatively) (JJ young) )
              (NNS diabetics) )
            (SBAR 
              (WHNP-1 (WP who) )
              (S 
                (NP-SBJ (-NONE- *T*-1) )
                (VP (VBD had) 
                  (VP (VBN switched) 
                    (PP-CLR (IN from) 
                      (NP (NN animal) ))
                    (PP-CLR (TO to) 
                      (NP (JJ human) (NN insulin) ))
                    (PP-TMP (IN within) 
                      (NP (DT the) (JJ past) (NN year) ))))))))))
    (, ,) 
    (NP-SBJ (PRP he) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-2) )))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (NNP Dr.) (NNP Solomon) (NNP Sobel) )
      (, ,) 
      (NP 
        (NP (NN director) )
        (PP (IN of) 
          (NP (NN metabolism) 
            (CC and)
            (JJ endrocrine) (NN drug) (NNS products) ))
        (PP (IN for) 
          (NP (DT the) (NNP U.S.) (NNP Food) 
            (CC and)
            (NNP Drug) (NNP Administration) )))
      (, ,) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ (NNP FDA) (NNS officials) )
          (VP (VBP have) 
            (VP (VBN discussed) 
              (NP 
                (NP (NNP Dr.) (NNP Toseland) (POS 's) )
                (NNS findings) )
              (`` ``) 
              (ADVP-MNR (RB fairly) (RB intensively) ))))))
    (. .) ('' '') ))
( (S 
    (SBAR-ADV (IN While) 
      (S 
        (NP-SBJ (EX there) )
        (VP (VBP have) 
          (VP (VBN been) 
            (NP-PRD 
              (NP (DT no) (NNS reports) )
              (PP (IN of) 
                (NP 
                  (NP (JJ similar) (JJ sudden) (JJ unexplained) (NNS deaths) )
                  (PP-LOC (IN among) 
                    (NP 
                      (NP (NNS diabetics) )
                      (PP-LOC (IN in) 
                        (NP (DT the) (NNP U.S.) )))))))))))
    (, ,) 
    (NP-SBJ (NNP Dr.) (NNP Sobel) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ-1 (DT the) (NNP FDA) )
          (VP 
            (VP (NNS plans) 
              (S 
                (NP-SBJ (-NONE- *-1) )
                (VP (TO to) 
                  (VP (VB examine) 
                    (NP 
                      (NP (NNP Dr.) (NNP Toseland) (POS 's) )
                      (NN evidence) )))))
            (CC and) 
            (VP (VBZ is) 
              (VP (VBG considering) 
                (NP 
                  (NP (PRP$ its) (JJ own) (NN study) )
                  (ADVP-LOC (RB here) ))))))))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (NNP Dr.) (NNP Toseland) )
      (, ,) 
      (NP (DT a) (NN toxicologist) )
      (, ,) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ (PRP he) )
          (VP (VBD was) 
            (VP (VBG preparing) 
              (NP-2 (DT an) (NN article) )
              (PP-CLR (IN for) 
                (NP (DT a) (JJ British) (JJ forensic) (JJ medical) (NN journal) ))
              (S-ADV 
                (NP-SBJ (-NONE- *-2) )
                (VP (VBG raising) 
                  (NP (DT the) (NN possibility) 
                    (SBAR (IN that) 
                      (S 
                        (NP-SBJ (DT the) (NNS deaths) )
                        (VP (MD may) 
                          (VP (VB have) 
                            (VP (VBN occurred) 
                              (SBAR-TMP (IN after) 
                                (S 
                                  (NP-SBJ (JJ human) (NN insulin) )
                                  (VP (VBD blunted) 
                                    (NP 
                                      (NP (JJ critical) (NN warning) (NNS signs) )
                                      (VP (VBG indicating) 
                                        (NP 
                                          (NP 
                                            (NP (NN hypoglycemia) )
                                            (, ,) (CC or) 
                                            (NP (JJ low) (NN blood) (NN sugar) )
                                            (, ,) )
                                          (SBAR 
                                            (WHNP-1 (WDT which) )
                                            (S 
                                              (NP-SBJ (-NONE- *T*-1) )
                                              (VP (MD can) 
                                                (VP (VB kill) 
                                                  (NP (NNS diabetics) ))))))))))))))))))))))))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (DT The) (JJ usual) (NN warning) (NNS signs) )
      (PP (IN of) 
        (NP (NN hypoglycemia) )))
    (VP (VBP include) 
      (NP (NN sweating) 
        (, ,)
        (NN anxiety) 
        (CC and)
        (NNS cramps) ))
    (. .) ))
( (S 
    (PP (IN With) 
      (NP (JJ proper) (NN warning) ))
    (, ,) 
    (NP-SBJ-1 (NNS diabetics) )
    (VP (MD can) 
      (VP 
        (ADVP-MNR (RB easily) )
        (VB raise) 
        (NP (PRP$ their) (NN blood) (NN sugar) )
        (PP-CLR (TO to) 
          (NP (JJ safe) (NNS levels) ))
        (PP-MNR (IN by) 
          (S-NOM 
            (NP-SBJ (-NONE- *-1) )
            (VP (VBG eating) 
              (NP 
                (NP (NN sugar) )
                (CC or) 
                (NP (JJ sugary) (NN food) )))))))
    (. .) ))
( (S (`` ``) 
    (S-TPC-1 
      (NP-SBJ (DT The) (JJ anecdotal) (NN data) )
      (ADVP (RB certainly) )
      (VP (VBZ shows) 
        (SBAR (IN that) 
          (S 
            (NP-SBJ 
              (NP (DT some) )
              (PP (IN of) 
                (NP (DT the) (NNS people) )))
            (VP (VBD were) (RB not) 
              (ADJP-PRD (JJ aware) 
                (PP (IN of) 
                  (NP 
                    (NP (DT the) (JJ rapid) (NN onset) )
                    (PP (IN of) 
                      (NP (NN hypoglycemia) ))))))))))
    (, ,) ('' '') 
    (NP-SBJ (NNP Dr.) (NNP Toseland) )
    (VP (VBD said) 
      (S (-NONE- *T*-1) ))
    (. .) ))
( (S 
    (PP-LOC (IN At) 
      (NP 
        (NP (DT the) (NNP U.S.) (NNP National) (NNP Institutes) )
        (PP (IN of) 
          (NP (NNP Health) ))))
    (, ,) 
    (NP-SBJ 
      (NP (NNP Dr.) (NNP Robert) (NNP E.) (NNP Silverman) )
      (, ,) 
      (NP 
        (NP (NN chief) )
        (PP (IN of) 
          (NP (DT the) (NN diabetes) (NN program) (NN branch) )))
      (, ,) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ 
            (NP (DT no) (NN evidence) )
            (PP (IN of) 
              (NP 
                (NP (JJ unexpected) (NNS deaths) )
                (PP (IN from) 
                  (NP (NN hypoglycemia) )))))
          (VP (VBD had) 
            (VP (VBN shown) 
              (PRT (RP up) )
              (PP-LOC (IN in) 
                (NP 
                  (NP (DT a) (NN study) )
                  (PP (IN of) 
                    (NP (CD 1,500) (NNS diabetics) ))
                  (SBAR 
                    (WHNP-1 (WDT that) )
                    (S 
                      (NP-SBJ (-NONE- *T*-1) )
                      (VP (VBZ has) 
                        (VP (VBN been) 
                          (PP-PRD (IN under) 
                            (NP (NN way) ))
                          (PP-LOC (IN at) 
                            (NP (NNP NIH) ))
                          (PP-TMP (IN for) 
                            (NP (CD five) (NNS years) )))))))))))))
    (. .) ))
( (S 
    (ADVP (RB However) )
    (, ,) 
    (NP-SBJ (PRP he) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ 
            (NP (NNS officials) )
            (VP (VBG conducting) 
              (NP (DT the) (NN study) )))
          (VP (VBD had) (RB n't) 
            (VP (VBN been) 
              (VP (VBG looking) 
                (PP-CLR (IN for) 
                  (NP 
                    (NP (NNS signs) )
                    (PP (IN of) 
                      (NP 
                        (NP (NNS problems) )
                        (ADJP (VBN related) 
                          (PP (TO to) 
                            (NP (NN hypoglycemia) (NN unawareness) )))))))))))))
    (. .) ))
( (S (`` ``) 
    (S-TPC-1 
      (NP-SBJ (PRP We) )
      (VP (VBP are) 
        (ADVP-TMP (RB now) )
        (VP (VBG monitoring) 
          (PP-CLR (IN for) 
            (NP (PRP it) ))
          (ADVP-MNR (RB much) (RBR more) (RB closely) ))))
    (, ,) ('' '') 
    (NP-SBJ (PRP he) )
    (VP (VBD said) 
      (S (-NONE- *T*-1) ))
    (. .) ))
( (S (`` ``) 
    (S-TPC-1 
      (NP-SBJ (PRP We) )
      (VP (VBP do) 
        (VP (VB know) 
          (SBAR (-NONE- 0) 
            (S 
              (NP-SBJ (EX there) )
              (VP (VBP are) 
                (NP-PRD 
                  (NP (JJ slight) (NNS differences) )
                  (PP-LOC (IN in) 
                    (NP 
                      (NP (DT the) (NN way) )
                      (SBAR 
                        (WHADVP-2 (-NONE- 0) )
                        (S 
                          (NP-SBJ 
                            (ADJP (JJ human) 
                              (CC and)
                              (JJ animal) )
                            (NNS insulins) )
                          (VP (VBP drive) 
                            (PRT (RP down) )
                            (NP (NN blood) (NN sugar) )
                            (ADVP-MNR (-NONE- *T*-2) )))))))))))))
    (, ,) ('' '') 
    (NP-SBJ (NNP Dr.) (NNP Sobel) )
    (VP (VBD said) 
      (S (-NONE- *T*-1) ))
    (. .) ))
( (S 
    (S-TPC-1 
      (NP-SBJ (DT The) (JJ human-based) (NN drug) )
      (VP 
        (VP (VBZ starts) 
          (NP (DT the) (NN blood) (NN sugar) (VBG dropping) )
          (ADVP-TMP (RBR sooner) ))
        (CC and) 
        (VP (VBZ drives) 
          (NP (PRP it) )
          (PRT (RP down) )
          (ADVP-MNR (RBR faster) ))))
    (, ,) 
    (NP-SBJ (PRP he) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-1) )))
    (. .) ))
( (S (`` ``) 
    (S-TPC-1 (CC But) 
      (NP-SBJ (PRP we) )
      (VP (VBP do) (RB n't) 
        (VP (VB believe) 
          (SBAR (-NONE- 0) 
            (S 
              (NP-SBJ (EX there) )
              (VP (VBZ is) 
                (ADJP-PRD (JJ enough) 
                  (PP (IN of) 
                    (NP (DT a) (NN difference) ))
                  (S 
                    (NP-SBJ (-NONE- *) )
                    (VP (TO to) 
                      (VP (VB be) 
                        (ADJP-PRD (RB clinically) (JJ significant) )))))))))))
    (, ,) ('' '') 
    (NP-SBJ (NNP Dr.) (NNP Sobel) )
    (VP (VBD said) 
      (S (-NONE- *T*-1) ))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (NNS Reports) )
      (PP (IN of) 
        (NP 
          (NP (NNP Dr.) (NNP Toseland) (POS 's) )
          (NNS findings) ))
      (PP-LOC (IN in) 
        (NP (DT the) (JJ British) (NN press) )))
    (VP (VBP have) 
      (VP (VBN triggered) 
        (NP (JJ widespread) (NN concern) )
        (PP-LOC (IN among) 
          (NP 
            (NP (NNS diabetics) )
            (ADVP-LOC (RB there) )))))
    (. .) ))
( (S 
    (NP-SBJ (DT Both) 
      (NP (DT the) (NNP British) (NNP Diabetic) (NNP Association) )
      (CC and) 
      (NP 
        (NP (DT the) (NNP Committee) )
        (PP (IN on) 
          (NP 
            (NP (NNP Safety) )
            (PP-LOC (IN in) 
              (NP (NNP Medicines) ))))
        (PRN (: --) 
          (NP 
            (NP 
              (NP (NNP Britain) (POS 's) )
              (NN equivalent) )
            (PP (IN of) 
              (NP (DT the) (NNP U.S.) (NNP FDA) )))
          (: --) )))
    (ADVP-TMP (RB recently) )
    (VP (VBD issued) 
      (NP 
        (NP (NNS statements) )
        (VP (VBG noting) 
          (NP 
            (NP (DT the) (NN lack) )
            (PP (IN of) 
              (NP 
                (NP (JJ hard) (JJ scientific) (NN evidence) )
                (SBAR 
                  (WHNP-1 (-NONE- 0) )
                  (S 
                    (NP-SBJ (-NONE- *T*-1) )
                    (VP (TO to) 
                      (VP (VB support) 
                        (NP 
                          (NP (NNP Dr.) (NNP Toseland) (POS 's) )
                          (NNS findings) )))))))))))
    (. .) ))
( (S 
    (PP-TMP (IN On) 
      (NP (NNP Friday) ))
    (, ,) 
    (NP-SBJ (DT the) (NNP American) (NNP Diabetes) (NNP Association) )
    (VP (VBD issued) 
      (NP 
        (NP (DT a) (JJ similar) (NN statement) )
        (VP (VBG urging) 
          (NP-1 (DT the) 
            (QP (CD six) (CD million) )
            (NNP U.S.) (NNS diabetics) )
          (S 
            (NP-SBJ (-NONE- *-1) )
            (RB not) 
            (VP (TO to) 
              (VP (VB overreact) 
                (PP-CLR (TO to) 
                  (NP (DT the) (JJ British) (NN report) ))))))))
    (. .) ))
( (S (`` ``) 
    (S-TPC-2 
      (NP-SBJ 
        (NP (DT A) (NN loss) )
        (PP (IN of) 
          (NP 
            (NP (DT the) (NN warning) (NNS symptoms) )
            (PP (IN of) 
              (NP (NN hypoglycemia) )))))
      (VP (VBZ is) 
        (NP-PRD 
          (NP (DT a) (JJ complex) (NN problem) )
          (SBAR 
            (WHNP-1 (WDT that) )
            (S 
              (NP-SBJ-3 (-NONE- *T*-1) )
              (VP (VBZ is) 
                (ADJP-PRD (RB very) (JJ unlikely) 
                  (S 
                    (NP-SBJ (-NONE- *-3) )
                    (VP (TO to) 
                      (VP (VB be) 
                        (ADVP-PRD (RB due) 
                          (PP 
                            (ADVP (RB simply) )
                            (TO to) 
                            (NP 
                              (NP (DT the) (NN type) )
                              (PP (IN of) 
                                (NP (NN insulin) ))
                              (VP (VBN used) 
                                (NP (-NONE- *) )))))))))))))))
    (, ,) ('' '') 
    (NP-SBJ (DT the) (JJ American) (NN association) )
    (VP (VBD said) 
      (S (-NONE- *T*-2) ))
    (. .) ))
( (S 
    (NP-SBJ (DT The) (NNP FDA) )
    (ADVP-TMP (RB already) )
    (VP (VBZ requires) 
      (S 
        (NP-SBJ (NN drug) (NNS manufacturers) )
        (VP (TO to) 
          (VP (VB include) 
            (NP (NNS warnings) 
              (SBAR (-NONE- *ICH*-1) ))
            (PP-CLR (IN with) 
              (NP (NN insulin) (NNS products) ))
            (SBAR-1 (IN that) 
              (S 
                (NP-SBJ 
                  (NP (NNS symptoms) )
                  (PP (IN of) 
                    (NP (NN hypoglycemia) )))
                (VP (VBP are) 
                  (ADJP-PRD 
                    (ADJP (RBR less) (JJ pronounced) )
                    (PP (IN with) 
                      (NP (JJ human) (NN insulin) ))
                    (PP (IN than) 
                      (PP (IN with) 
                        (NP (JJ animal-based) (NNS products) )))))))))))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (NNP Eli) (NNP Lilly) (CC &) (NNP Co.) )
      (, ,) 
      (NP (DT the) (JJ Indianapolis-based) (NN drug) (NN manufacturer) )
      (, ,) )
    (VP (VBZ dominates) 
      (NP (DT the) (NNP U.S.) (JJ human) (NN insulin) (NN market) )
      (PP (IN with) 
        (NP 
          (NP (PRP$ its) (NN product) )
          (VP (VBN known) 
            (NP (-NONE- *) )
            (PP-CLR (IN as) 
              (NP (NNP Humulin) ))))))
    (. .) ))
( (S 
    (NP-SBJ (NNP Lilly) )
    (VP (VBZ is) 
      (VP (VBG building) 
        (NP 
          (NP (NNS plants) )
          (SBAR 
            (WHADVP-1 (-NONE- 0) )
            (S 
              (NP-SBJ (-NONE- *) )
              (VP (TO to) 
                (VP (VB make) 
                  (NP (DT the) (NN insulin) )
                  (ADVP-LOC (-NONE- *T*-1) ))))))
        (PP-LOC (IN in) 
          (NP 
            (NP (NNP Indianapolis) )
            (CC and) 
            (NP 
              (NP (NNP Fagershein) )
              (, ,) 
              (NP-LOC (NNP France) ))))))
    (. .) ))
( (S 
    (PP-LOC (IN In) 
      (NP (PRP$ its) (JJS latest) (JJ annual) (NN report) ))
    (, ,) 
    (NP-SBJ (NNP Lilly) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ (NNP Humulin) (NNS sales) )
          (VP (VBP have) 
            (VP (VBN shown) (`` ``) 
              (NP (JJ excellent) (NN growth) ))))))
    (. .) ('' '') ))
( (S 
    (NP-SBJ (NNP Lilly) (NNS officials) )
    (VP 
      (VP (VBD said) 
        (SBAR (-NONE- 0) 
          (S 
            (NP-SBJ (PRP they) )
            (VP (VBD had) 
              (VP (VBN seen) 
                (NP 
                  (NP (NNS reports) )
                  (PP (IN of) 
                    (NP 
                      (NP (JJ hypoglycemic) (NN unawareness) )
                      (PP-LOC (IN among) 
                        (NP 
                          (NP (DT some) (NNS patients) )
                          (VP (VBG making) 
                            (NP 
                              (NP (DT the) (NN shift) )
                              (PP (IN from) 
                                (ADJP (JJ animal) ))
                              (PP (TO to) 
                                (NP (JJ human) (NN insulin) ))))))))))))))
      (, ,) (CC but) 
      (VP (VBD did) (RB n't) 
        (VP (VB know) 
          (SBAR (IN if) 
            (S 
              (NP-SBJ (DT the) (NN problem) )
              (VP (VBD had) 
                (VP (VBN caused) 
                  (NP (DT any) (NNS deaths) ))))))))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (NNP Dr.) (NNP Leigh) (NNP Thompson) )
      (, ,) 
      (NP (DT a) (NNP Lilly) (NN group) (NN vice) (NN president) )
      (, ,) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ 
            (NP 
              (NP (DT the) (NN company) (POS 's) )
              (JJ clinical) (NNS trials) )
            (PP (IN of) 
              (NP (CC both) (PRP$ its) 
                (ADJP (JJ animal) 
                  (CC and)
                  (JJ human-based) )
                (NNS insulins) )))
          (VP (VBD indicated) 
            (NP 
              (NP (DT no) (NN difference) )
              (PP-LOC (IN in) 
                (NP 
                  (NP (DT the) (NN level) )
                  (PP (IN of) 
                    (NP (NN hypoglycemia) ))))
              (PP-LOC (IN between) 
                (NP 
                  (NP (NNS users) )
                  (PP (IN of) 
                    (NP (DT either) (NN product) )))))))))
    (. .) ))
( (S 
    (NP-SBJ (NNP Dr.) (NNP Toseland) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ 
            (NP (JJS most) )
            (PP (IN of) 
              (NP (DT the) (JJ British) (NNS diabetics) ))
            (SBAR 
              (WHNP-1 (WP who) )
              (S 
                (NP-SBJ (-NONE- *T*-1) )
                (VP (VBD died) ))))
          (VP (VBD had) 
            (VP (VBN been) 
              (VP (VBG taking) 
                (NP 
                  (NP (DT a) (JJ human-based) (NN insulin) )
                  (VP (VBN made) 
                    (NP (-NONE- *) )
                    (PP (IN by) 
                      (NP-LGS 
                        (NP (NNP Novo\/Nordisk) )
                        (, ,) 
                        (NP (DT a) (JJ Danish) (NN manufacturer) )))))))))))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (NN None) )
      (PP (IN of) 
        (NP (DT the) (NNS diabetics) )))
    (VP (VBD were) 
      (VP (VBG using) 
        (NP 
          (NP (NNP Lilly) (POS 's) )
          (NN insulin) )))
    (. .) ))
